✦ LIBER ✦

Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine® in previously treated patients with severe haemophilia B

✍ Scribed by M. SERBAN; A. B. SKOTNICKI; M. COLOVIC; C. JINCA; A. KLUKOWSKA; P. LAGUNA; D. M. WOLF

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical efficacy, safety and pharmacoki

✍ D. M. Wolf; R. Rokicka-Milewska; S. Lopaciuk; A. B. Skotnicki; A. Klukowska; P. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Pharmacokinetic study of a high-purity f

✍ J. A. AZNAR; N. CABRERA; M. MATYSIAK; K. ZAWILSKA; L. GERCHEVA; A. ANTONOV; M. M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

An open clinical study assessing the eff

✍ T. LISSITCHKOV; M. MATYSIAK; K. ZAWILSKA; L. GERCHEVA; A. ANTONOV; M. MONTAÑES; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

A clinical study assessing the pharmacok

✍ T. LISSITCHKOV; M. MATYSIAK; K. ZAVILSKA; P. ŁAGUNA; L. GERCHEVA; A. ANTONOV; N. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Safety and efficacy of plasma-derived co

✍ D. V. K. QUON; L. LOGAN 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Interim data on long-term efficacy, safe

✍ L. NEMES; H. POLLMANN; T. BECKER 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB